Related Experiment Video
Updated: Aug 24, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Effect of Comorbidities on the Infection Rate and Severity of COVID-19: Nationwide Cohort Study With Propensity Score
Jiyong Kim1, Seong Hun Park2, Jong Moon Kim3,4
1Department of Rehabilitation, Inje University Ilsanpaik Hospital, Goyang, Republic of Korea.
Insights
COVID-19 infection and severity were lower in individuals with hyperlipidemia, especially those using statins. This finding highlights the potential protective role of managing hyperlipidemia in the context of COVID-19.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Despite vaccine development, COVID-19 transmission persists, with ongoing research into comorbidity impacts yielding contradictory results.
- Understanding demographic and comorbidity influences on COVID-19 infection and severity is crucial for public health strategies.
Purpose of the Study:
- To investigate the impact of patient demographics and comorbidities on COVID-19 infection rates and severity.
- To analyze real-world data from South Korea to identify risk and protective factors for COVID-19.
Main Methods:
- Utilized a nationwide South Korean COVID-19 cohort study with propensity score (PS) matching.
- Included 8070 COVID-19 positive individuals and 8070 matched uninfected controls (January-May 2020).
- Analyzed outcomes including infection positivity and severe clinical events, adjusting for confounders via PS matching.
Main Results:
- Individuals aged 60+, Medicaid recipients, and those with disabilities showed higher severe COVID-19 outcomes.
- Pulmonary disease, dementia, gastrointestinal disease, and stroke increased COVID-19 infection risk.
- Hyperlipidemia, autoimmune disease, and cancer were associated with lower infection rates.
- Kidney disease, hypertension, dementia, and cancer significantly increased COVID-19 severity.
- Hyperlipidemia was associated with lower COVID-19 infection rates and severity.
Conclusions:
- Hyperlipidemia may be associated with reduced COVID-19 infection rates and disease severity, particularly when managed with statins.
- These findings underscore the importance of managing comorbidities like hyperlipidemia in mitigating COVID-19's impact.
Background:
A vaccine against COVID-19 has been developed; however, COVID-19 transmission continues. Although there have been many studies of comorbidities that have important roles in COVID-19, some studies have reported contradictory results.
Objective:
This study was conducted using real-world data from COVID-19 patients in South Korea and aimed to investigate the impact of patient demographics and comorbidities on the infection rate and severity of COVID-19.
Methods:
Data were derived from a nationwide South Korean COVID-19 cohort study with propensity score (PS) matching. We included infected individuals who were COVID-19-positive between January 1, 2020, and May 30, 2020, and PS-matched uninfected controls. PS matching was performed to balance the baseline characteristics of each comorbidity and to adjust for potential confounders, such as age, sex, Charlson Comorbidity Index, medication, and other comorbidities, that were matched with binary variables. The outcomes were the confirmed comorbidities affecting the infection rate and severity of COVID-19. The endpoints were COVID-19 positivity and severe clinical outcomes of COVID-19 (such as tracheostomy, continuous renal replacement therapy, intensive care unit admission, ventilator use, cardiopulmonary resuscitation, and death).
Results:
The COVID-19 cohort with PS matching included 8070 individuals with positive COVID-19 test results and 8070 matched controls. The proportions of patients in the severe group were higher for individuals 60 years or older (severe clinical outcomes for those 60 years or older, 16.52%; severe clinical outcomes for those of other ages, 2.12%), those insured with Medicaid (Medicaid, 10.81%; other insurance, 5.61%), and those with disabilities (with disabilities, 18.26%; without disabilities, 5.07%). The COVID-19 infection rate was high for patients with pulmonary disease (odds ratio [OR] 1.88; 95% CI 1.70-2.03), dementia (OR 1.75; 95% CI 1.40-2.20), gastrointestinal disease (OR 1.74; 95% CI 1.62-1.88), stroke (OR 1.67; 95% CI 1.23-2.27), hepatobiliary disease (OR 1.31; 95% CI 1.19-1.44), diabetes mellitus (OR 1.28; 95% CI 1.16-1.43), and cardiovascular disease (OR 1.20; 95% CI 1.07-1.35). In contrast, it was lower for individuals with hyperlipidemia (OR 0.73; 95% CI 0.67-0.80), autoimmune disease (OR 0.73; 95% CI 0.60-0.89), and cancer (OR 0.73; 95% CI 0.62-0.86). The severity of COVID-19 was high for individuals with kidney disease (OR 5.59; 95% CI 2.48-12.63), hypertension (OR 2.92; 95% CI 1.91-4.47), dementia (OR 2.92; 95% CI 1.91-4.47), cancer (OR 1.84; 95% CI 1.15-2.94), pulmonary disease (OR 1.72; 95% CI 1.35-2.19), cardiovascular disease (OR 1.54; 95% CI 1.17-2.04), diabetes mellitus (OR 1.43; 95% CI 1.09-1.87), and psychotic disorders (OR 1.29; 95% CI 1.01-6.52). However, it was low for those with hyperlipidemia (OR 0.78; 95% CI 0.60-1.00).
Conclusions:
Upon PS matching considering the use of statins, it was concluded that people with hyperlipidemia could have lower infection rates and disease severity of COVID-19.
More Related Videos
03:53Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Confounding in Epidemiological Studies
Bias in Epidemiological Studies
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Causality in Epidemiology